{"id":"https://openalex.org/W1994094087","doi":"https://doi.org/10.1111/j.1552-6569.2010.00515.x","title":"Structural Brain Changes in Patients with Recurrent Major Depressive Disorder Presenting with Anxiety Symptoms","display_name":"Structural Brain Changes in Patients with Recurrent Major Depressive Disorder Presenting with Anxiety Symptoms","publication_year":2010,"publication_date":"2010-10-26","ids":{"openalex":"https://openalex.org/W1994094087","doi":"https://doi.org/10.1111/j.1552-6569.2010.00515.x","mag":"1994094087","pmid":"https://pubmed.ncbi.nlm.nih.gov/20977527"},"language":"en","primary_location":{"id":"doi:10.1111/j.1552-6569.2010.00515.x","doi":"https://doi.org/10.1111/j.1552-6569.2010.00515.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1552-6569.2010.00515.x","pdf_url":null,"source":{"id":"https://openalex.org/S143223179","display_name":"Journal of Neuroimaging","issn_l":"1051-2284","issn":["1051-2284","1552-6569"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Neuroimaging","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019826497","display_name":"Becky Inkster","orcid":"https://orcid.org/0000-0003-1201-455X","observed_orcids":["https://orcid.org/0000-0003-1201-455X"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I2801748203","display_name":"Hammersmith Hospital","ror":"https://ror.org/05jg8yp15","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I153355300","https://openalex.org/I2801748203"]},{"id":"https://openalex.org/I4210128413","display_name":"GlaxoSmithKline (Italy)","ror":"https://ror.org/03fe56089","country_code":"IT","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210128413"]},{"id":"https://openalex.org/I4210145969","display_name":"Max Planck Institute of Psychiatry","ror":"https://ror.org/04dq56617","country_code":"DE","type":"facility","lineage":["https://openalex.org/I149899117","https://openalex.org/I4210145969"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["DE","GB","IT"],"is_corresponding":false,"raw_author_name":"Becky Inkster","raw_affiliation_strings":["GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital, London, UK. b.inkster@imperial.ac.uk","Department of Clinical Neuroscience, Imperial College, London, UK (BI, PMM)","Experimental Medical Science, Psychiatry Centre of Excellence for Drug Discovery, Harlow-Verona, GlaxoSmithKline (EM)","From the GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital, London, UK (BI, AWR, KR, TEN, PMM)","Genetics Division, Drug Discovery, Medicine Development Centre, GlaxoSmithKline, Research and Development, Verona, Italy (FT, PM)","Max Planck Institute of Psychiatry, Munich, Germany (PGS, DPA, FH)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital, London, UK. b.inkster@imperial.ac.uk","institution_ids":["https://openalex.org/I2801748203"]},{"raw_affiliation_string":"Department of Clinical Neuroscience, Imperial College, London, UK (BI, PMM)","institution_ids":["https://openalex.org/I47508984"]},{"raw_affiliation_string":"Experimental Medical Science, Psychiatry Centre of Excellence for Drug Discovery, Harlow-Verona, GlaxoSmithKline (EM)","institution_ids":["https://openalex.org/I188950975"]},{"raw_affiliation_string":"From the GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital, London, UK (BI, AWR, KR, TEN, PMM)","institution_ids":["https://openalex.org/I2801748203"]},{"raw_affiliation_string":"Genetics Division, Drug Discovery, Medicine Development Centre, GlaxoSmithKline, Research and Development, Verona, Italy (FT, PM)","institution_ids":["https://openalex.org/I4210128413"]},{"raw_affiliation_string":"Max Planck Institute of Psychiatry, Munich, Germany (PGS, DPA, FH)","institution_ids":["https://openalex.org/I4210145969"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102089298","display_name":"Anil W. Rao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I2801748203","display_name":"Hammersmith Hospital","ror":"https://ror.org/05jg8yp15","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I153355300","https://openalex.org/I2801748203"]},{"id":"https://openalex.org/I4210128413","display_name":"GlaxoSmithKline (Italy)","ror":"https://ror.org/03fe56089","country_code":"IT","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210128413"]},{"id":"https://openalex.org/I4210145969","display_name":"Max Planck Institute of Psychiatry","ror":"https://ror.org/04dq56617","country_code":"DE","type":"facility","lineage":["https://openalex.org/I149899117","https://openalex.org/I4210145969"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["DE","GB","IT"],"is_corresponding":false,"raw_author_name":"Anil W. Rao","raw_affiliation_strings":["From the GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital, London, UK (BI, AWR, KR, TEN, PMM); Max Planck Institute of Psychiatry, Munich, Germany (PGS, DPA, FH); Genetics Division, Drug Discovery, Medicine Development Centre, GlaxoSmithKline, Research and Development, Verona, Italy (FT, PM); Experimental Medical Science, Psychiatry Centre of Excellence for Drug Discovery, Harlow-Verona, GlaxoSmithKline (EM); Department of Clinical Neuroscience, Imperial College, London, UK (BI, PMM)","Department of Clinical Neuroscience, Imperial College, London, UK (BI, PMM)","Experimental Medical Science, Psychiatry Centre of Excellence for Drug Discovery, Harlow-Verona, GlaxoSmithKline (EM)","From the GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital, London, UK (BI, AWR, KR, TEN, PMM)","Genetics Division, Drug Discovery, Medicine Development Centre, GlaxoSmithKline, Research and Development, Verona, Italy (FT, PM)","Max Planck Institute of Psychiatry, Munich, Germany (PGS, DPA, FH)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital, London, UK (BI, AWR, KR, TEN, PMM); Max Planck Institute of Psychiatry, Munich, Germany (PGS, DPA, FH); Genetics Division, Drug Discovery, Medicine Development Centre, GlaxoSmithKline, Research and Development, Verona, Italy (FT, PM); Experimental Medical Science, Psychiatry Centre of Excellence for Drug Discovery, Harlow-Verona, GlaxoSmithKline (EM); Department of Clinical Neuroscience, Imperial College, London, UK (BI, PMM)","institution_ids":["https://openalex.org/I188950975","https://openalex.org/I2801748203","https://openalex.org/I4210128413","https://openalex.org/I4210145969","https://openalex.org/I47508984"]},{"raw_affiliation_string":"Department of Clinical Neuroscience, Imperial College, London, UK (BI, PMM)","institution_ids":["https://openalex.org/I47508984"]},{"raw_affiliation_string":"Experimental Medical Science, Psychiatry Centre of Excellence for Drug Discovery, Harlow-Verona, GlaxoSmithKline (EM)","institution_ids":["https://openalex.org/I188950975"]},{"raw_affiliation_string":"From the GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital, London, UK (BI, AWR, KR, TEN, PMM)","institution_ids":["https://openalex.org/I2801748203"]},{"raw_affiliation_string":"Genetics Division, Drug Discovery, Medicine Development Centre, GlaxoSmithKline, Research and Development, Verona, Italy (FT, PM)","institution_ids":["https://openalex.org/I4210128413"]},{"raw_affiliation_string":"Max Planck Institute of Psychiatry, Munich, Germany (PGS, DPA, FH)","institution_ids":["https://openalex.org/I4210145969"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048644624","display_name":"Khanum Ridler","orcid":"https://orcid.org/0009-0005-1809-058X","observed_orcids":["https://orcid.org/0009-0005-1809-058X"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I2801748203","display_name":"Hammersmith Hospital","ror":"https://ror.org/05jg8yp15","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I153355300","https://openalex.org/I2801748203"]},{"id":"https://openalex.org/I4210128413","display_name":"GlaxoSmithKline (Italy)","ror":"https://ror.org/03fe56089","country_code":"IT","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210128413"]},{"id":"https://openalex.org/I4210145969","display_name":"Max Planck Institute of Psychiatry","ror":"https://ror.org/04dq56617","country_code":"DE","type":"facility","lineage":["https://openalex.org/I149899117","https://openalex.org/I4210145969"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["DE","GB","IT"],"is_corresponding":false,"raw_author_name":"Khanum Ridler","raw_affiliation_strings":["From the GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital, London, UK (BI, AWR, KR, TEN, PMM); Max Planck Institute of Psychiatry, Munich, Germany (PGS, DPA, FH); Genetics Division, Drug Discovery, Medicine Development Centre, GlaxoSmithKline, Research and Development, Verona, Italy (FT, PM); Experimental Medical Science, Psychiatry Centre of Excellence for Drug Discovery, Harlow-Verona, GlaxoSmithKline (EM); Department of Clinical Neuroscience, Imperial College, London, UK (BI, PMM)","Department of Clinical Neuroscience, Imperial College, London, UK (BI, PMM)","Experimental Medical Science, Psychiatry Centre of Excellence for Drug Discovery, Harlow-Verona, GlaxoSmithKline (EM)","From the GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital, London, UK (BI, AWR, KR, TEN, PMM)","Genetics Division, Drug Discovery, Medicine Development Centre, GlaxoSmithKline, Research and Development, Verona, Italy (FT, PM)","Max Planck Institute of Psychiatry, Munich, Germany (PGS, DPA, FH)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital, London, UK (BI, AWR, KR, TEN, PMM); Max Planck Institute of Psychiatry, Munich, Germany (PGS, DPA, FH); Genetics Division, Drug Discovery, Medicine Development Centre, GlaxoSmithKline, Research and Development, Verona, Italy (FT, PM); Experimental Medical Science, Psychiatry Centre of Excellence for Drug Discovery, Harlow-Verona, GlaxoSmithKline (EM); Department of Clinical Neuroscience, Imperial College, London, UK (BI, PMM)","institution_ids":["https://openalex.org/I188950975","https://openalex.org/I2801748203","https://openalex.org/I4210128413","https://openalex.org/I4210145969","https://openalex.org/I47508984"]},{"raw_affiliation_string":"Department of Clinical Neuroscience, Imperial College, London, UK (BI, PMM)","institution_ids":["https://openalex.org/I47508984"]},{"raw_affiliation_string":"Experimental Medical Science, Psychiatry Centre of Excellence for Drug Discovery, Harlow-Verona, GlaxoSmithKline (EM)","institution_ids":["https://openalex.org/I188950975"]},{"raw_affiliation_string":"From the GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital, London, UK (BI, AWR, KR, TEN, PMM)","institution_ids":["https://openalex.org/I2801748203"]},{"raw_affiliation_string":"Genetics Division, Drug Discovery, Medicine Development Centre, GlaxoSmithKline, Research and Development, Verona, Italy (FT, PM)","institution_ids":["https://openalex.org/I4210128413"]},{"raw_affiliation_string":"Max Planck Institute of Psychiatry, Munich, Germany (PGS, DPA, FH)","institution_ids":["https://openalex.org/I4210145969"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056453682","display_name":"Thomas E. Nichols","orcid":"https://orcid.org/0000-0002-4516-5103","observed_orcids":["https://orcid.org/0000-0002-4516-5103"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I2801748203","display_name":"Hammersmith Hospital","ror":"https://ror.org/05jg8yp15","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I153355300","https://openalex.org/I2801748203"]},{"id":"https://openalex.org/I4210128413","display_name":"GlaxoSmithKline (Italy)","ror":"https://ror.org/03fe56089","country_code":"IT","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210128413"]},{"id":"https://openalex.org/I4210145969","display_name":"Max Planck Institute of Psychiatry","ror":"https://ror.org/04dq56617","country_code":"DE","type":"facility","lineage":["https://openalex.org/I149899117","https://openalex.org/I4210145969"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["DE","GB","IT"],"is_corresponding":false,"raw_author_name":"Thomas E. Nichols","raw_affiliation_strings":["From the GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital, London, UK (BI, AWR, KR, TEN, PMM); Max Planck Institute of Psychiatry, Munich, Germany (PGS, DPA, FH); Genetics Division, Drug Discovery, Medicine Development Centre, GlaxoSmithKline, Research and Development, Verona, Italy (FT, PM); Experimental Medical Science, Psychiatry Centre of Excellence for Drug Discovery, Harlow-Verona, GlaxoSmithKline (EM); Department of Clinical Neuroscience, Imperial College, London, UK (BI, PMM)","Department of Clinical Neuroscience, Imperial College, London, UK (BI, PMM)","Experimental Medical Science, Psychiatry Centre of Excellence for Drug Discovery, Harlow-Verona, GlaxoSmithKline (EM)","From the GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital, London, UK (BI, AWR, KR, TEN, PMM)","Genetics Division, Drug Discovery, Medicine Development Centre, GlaxoSmithKline, Research and Development, Verona, Italy (FT, PM)","Max Planck Institute of Psychiatry, Munich, Germany (PGS, DPA, FH)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital, London, UK (BI, AWR, KR, TEN, PMM); Max Planck Institute of Psychiatry, Munich, Germany (PGS, DPA, FH); Genetics Division, Drug Discovery, Medicine Development Centre, GlaxoSmithKline, Research and Development, Verona, Italy (FT, PM); Experimental Medical Science, Psychiatry Centre of Excellence for Drug Discovery, Harlow-Verona, GlaxoSmithKline (EM); Department of Clinical Neuroscience, Imperial College, London, UK (BI, PMM)","institution_ids":["https://openalex.org/I188950975","https://openalex.org/I2801748203","https://openalex.org/I4210128413","https://openalex.org/I4210145969","https://openalex.org/I47508984"]},{"raw_affiliation_string":"Department of Clinical Neuroscience, Imperial College, London, UK (BI, PMM)","institution_ids":["https://openalex.org/I47508984"]},{"raw_affiliation_string":"Experimental Medical Science, Psychiatry Centre of Excellence for Drug Discovery, Harlow-Verona, GlaxoSmithKline (EM)","institution_ids":["https://openalex.org/I188950975"]},{"raw_affiliation_string":"From the GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital, London, UK (BI, AWR, KR, TEN, PMM)","institution_ids":["https://openalex.org/I2801748203"]},{"raw_affiliation_string":"Genetics Division, Drug Discovery, Medicine Development Centre, GlaxoSmithKline, Research and Development, Verona, Italy (FT, PM)","institution_ids":["https://openalex.org/I4210128413"]},{"raw_affiliation_string":"Max Planck Institute of Psychiatry, Munich, Germany (PGS, DPA, FH)","institution_ids":["https://openalex.org/I4210145969"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112614516","display_name":"Philipp G. Saemann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I2801748203","display_name":"Hammersmith Hospital","ror":"https://ror.org/05jg8yp15","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I153355300","https://openalex.org/I2801748203"]},{"id":"https://openalex.org/I4210128413","display_name":"GlaxoSmithKline (Italy)","ror":"https://ror.org/03fe56089","country_code":"IT","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210128413"]},{"id":"https://openalex.org/I4210145969","display_name":"Max Planck Institute of Psychiatry","ror":"https://ror.org/04dq56617","country_code":"DE","type":"facility","lineage":["https://openalex.org/I149899117","https://openalex.org/I4210145969"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["DE","GB","IT"],"is_corresponding":false,"raw_author_name":"Philipp G. Saemann","raw_affiliation_strings":["From the GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital, London, UK (BI, AWR, KR, TEN, PMM); Max Planck Institute of Psychiatry, Munich, Germany (PGS, DPA, FH); Genetics Division, Drug Discovery, Medicine Development Centre, GlaxoSmithKline, Research and Development, Verona, Italy (FT, PM); Experimental Medical Science, Psychiatry Centre of Excellence for Drug Discovery, Harlow-Verona, GlaxoSmithKline (EM); Department of Clinical Neuroscience, Imperial College, London, UK (BI, PMM)","Department of Clinical Neuroscience, Imperial College, London, UK (BI, PMM)","Experimental Medical Science, Psychiatry Centre of Excellence for Drug Discovery, Harlow-Verona, GlaxoSmithKline (EM)","From the GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital, London, UK (BI, AWR, KR, TEN, PMM)","Genetics Division, Drug Discovery, Medicine Development Centre, GlaxoSmithKline, Research and Development, Verona, Italy (FT, PM)","Max Planck Institute of Psychiatry, Munich, Germany (PGS, DPA, FH)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital, London, UK (BI, AWR, KR, TEN, PMM); Max Planck Institute of Psychiatry, Munich, Germany (PGS, DPA, FH); Genetics Division, Drug Discovery, Medicine Development Centre, GlaxoSmithKline, Research and Development, Verona, Italy (FT, PM); Experimental Medical Science, Psychiatry Centre of Excellence for Drug Discovery, Harlow-Verona, GlaxoSmithKline (EM); Department of Clinical Neuroscience, Imperial College, London, UK (BI, PMM)","institution_ids":["https://openalex.org/I188950975","https://openalex.org/I2801748203","https://openalex.org/I4210128413","https://openalex.org/I4210145969","https://openalex.org/I47508984"]},{"raw_affiliation_string":"Department of Clinical Neuroscience, Imperial College, London, UK (BI, PMM)","institution_ids":["https://openalex.org/I47508984"]},{"raw_affiliation_string":"Experimental Medical Science, Psychiatry Centre of Excellence for Drug Discovery, Harlow-Verona, GlaxoSmithKline (EM)","institution_ids":["https://openalex.org/I188950975"]},{"raw_affiliation_string":"From the GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital, London, UK (BI, AWR, KR, TEN, PMM)","institution_ids":["https://openalex.org/I2801748203"]},{"raw_affiliation_string":"Genetics Division, Drug Discovery, Medicine Development Centre, GlaxoSmithKline, Research and Development, Verona, Italy (FT, PM)","institution_ids":["https://openalex.org/I4210128413"]},{"raw_affiliation_string":"Max Planck Institute of Psychiatry, Munich, Germany (PGS, DPA, FH)","institution_ids":["https://openalex.org/I4210145969"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078023911","display_name":"Dorothee P. Auer","orcid":"https://orcid.org/0000-0002-4745-3635","observed_orcids":["https://orcid.org/0000-0002-4745-3635"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I2801748203","display_name":"Hammersmith Hospital","ror":"https://ror.org/05jg8yp15","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I153355300","https://openalex.org/I2801748203"]},{"id":"https://openalex.org/I4210128413","display_name":"GlaxoSmithKline (Italy)","ror":"https://ror.org/03fe56089","country_code":"IT","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210128413"]},{"id":"https://openalex.org/I4210145969","display_name":"Max Planck Institute of Psychiatry","ror":"https://ror.org/04dq56617","country_code":"DE","type":"facility","lineage":["https://openalex.org/I149899117","https://openalex.org/I4210145969"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["DE","GB","IT"],"is_corresponding":false,"raw_author_name":"Dorothee P. Auer","raw_affiliation_strings":["From the GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital, London, UK (BI, AWR, KR, TEN, PMM); Max Planck Institute of Psychiatry, Munich, Germany (PGS, DPA, FH); Genetics Division, Drug Discovery, Medicine Development Centre, GlaxoSmithKline, Research and Development, Verona, Italy (FT, PM); Experimental Medical Science, Psychiatry Centre of Excellence for Drug Discovery, Harlow-Verona, GlaxoSmithKline (EM); Department of Clinical Neuroscience, Imperial College, London, UK (BI, PMM)","Department of Clinical Neuroscience, Imperial College, London, UK (BI, PMM)","Experimental Medical Science, Psychiatry Centre of Excellence for Drug Discovery, Harlow-Verona, GlaxoSmithKline (EM)","From the GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital, London, UK (BI, AWR, KR, TEN, PMM)","Genetics Division, Drug Discovery, Medicine Development Centre, GlaxoSmithKline, Research and Development, Verona, Italy (FT, PM)","Max Planck Institute of Psychiatry, Munich, Germany (PGS, DPA, FH)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital, London, UK (BI, AWR, KR, TEN, PMM); Max Planck Institute of Psychiatry, Munich, Germany (PGS, DPA, FH); Genetics Division, Drug Discovery, Medicine Development Centre, GlaxoSmithKline, Research and Development, Verona, Italy (FT, PM); Experimental Medical Science, Psychiatry Centre of Excellence for Drug Discovery, Harlow-Verona, GlaxoSmithKline (EM); Department of Clinical Neuroscience, Imperial College, London, UK (BI, PMM)","institution_ids":["https://openalex.org/I188950975","https://openalex.org/I2801748203","https://openalex.org/I4210128413","https://openalex.org/I4210145969","https://openalex.org/I47508984"]},{"raw_affiliation_string":"Department of Clinical Neuroscience, Imperial College, London, UK (BI, PMM)","institution_ids":["https://openalex.org/I47508984"]},{"raw_affiliation_string":"Experimental Medical Science, Psychiatry Centre of Excellence for Drug Discovery, Harlow-Verona, GlaxoSmithKline (EM)","institution_ids":["https://openalex.org/I188950975"]},{"raw_affiliation_string":"From the GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital, London, UK (BI, AWR, KR, TEN, PMM)","institution_ids":["https://openalex.org/I2801748203"]},{"raw_affiliation_string":"Genetics Division, Drug Discovery, Medicine Development Centre, GlaxoSmithKline, Research and Development, Verona, Italy (FT, PM)","institution_ids":["https://openalex.org/I4210128413"]},{"raw_affiliation_string":"Max Planck Institute of Psychiatry, Munich, Germany (PGS, DPA, FH)","institution_ids":["https://openalex.org/I4210145969"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Florian Holsboer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I2801748203","display_name":"Hammersmith Hospital","ror":"https://ror.org/05jg8yp15","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I153355300","https://openalex.org/I2801748203"]},{"id":"https://openalex.org/I4210128413","display_name":"GlaxoSmithKline (Italy)","ror":"https://ror.org/03fe56089","country_code":"IT","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210128413"]},{"id":"https://openalex.org/I4210145969","display_name":"Max Planck Institute of Psychiatry","ror":"https://ror.org/04dq56617","country_code":"DE","type":"facility","lineage":["https://openalex.org/I149899117","https://openalex.org/I4210145969"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["DE","GB","IT"],"is_corresponding":false,"raw_author_name":"Florian Holsboer","raw_affiliation_strings":["From the GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital, London, UK (BI, AWR, KR, TEN, PMM); Max Planck Institute of Psychiatry, Munich, Germany (PGS, DPA, FH); Genetics Division, Drug Discovery, Medicine Development Centre, GlaxoSmithKline, Research and Development, Verona, Italy (FT, PM); Experimental Medical Science, Psychiatry Centre of Excellence for Drug Discovery, Harlow-Verona, GlaxoSmithKline (EM); Department of Clinical Neuroscience, Imperial College, London, UK (BI, PMM)","Department of Clinical Neuroscience, Imperial College, London, UK (BI, PMM)","Experimental Medical Science, Psychiatry Centre of Excellence for Drug Discovery, Harlow-Verona, GlaxoSmithKline (EM)","From the GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital, London, UK (BI, AWR, KR, TEN, PMM)","Genetics Division, Drug Discovery, Medicine Development Centre, GlaxoSmithKline, Research and Development, Verona, Italy (FT, PM)","Max Planck Institute of Psychiatry, Munich, Germany (PGS, DPA, FH)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital, London, UK (BI, AWR, KR, TEN, PMM); Max Planck Institute of Psychiatry, Munich, Germany (PGS, DPA, FH); Genetics Division, Drug Discovery, Medicine Development Centre, GlaxoSmithKline, Research and Development, Verona, Italy (FT, PM); Experimental Medical Science, Psychiatry Centre of Excellence for Drug Discovery, Harlow-Verona, GlaxoSmithKline (EM); Department of Clinical Neuroscience, Imperial College, London, UK (BI, PMM)","institution_ids":["https://openalex.org/I188950975","https://openalex.org/I2801748203","https://openalex.org/I4210128413","https://openalex.org/I4210145969","https://openalex.org/I47508984"]},{"raw_affiliation_string":"Department of Clinical Neuroscience, Imperial College, London, UK (BI, PMM)","institution_ids":["https://openalex.org/I47508984"]},{"raw_affiliation_string":"Experimental Medical Science, Psychiatry Centre of Excellence for Drug Discovery, Harlow-Verona, GlaxoSmithKline (EM)","institution_ids":["https://openalex.org/I188950975"]},{"raw_affiliation_string":"From the GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital, London, UK (BI, AWR, KR, TEN, PMM)","institution_ids":["https://openalex.org/I2801748203"]},{"raw_affiliation_string":"Genetics Division, Drug Discovery, Medicine Development Centre, GlaxoSmithKline, Research and Development, Verona, Italy (FT, PM)","institution_ids":["https://openalex.org/I4210128413"]},{"raw_affiliation_string":"Max Planck Institute of Psychiatry, Munich, Germany (PGS, DPA, FH)","institution_ids":["https://openalex.org/I4210145969"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006541865","display_name":"Federica Tozzi","orcid":"https://orcid.org/0000-0002-3536-2920","observed_orcids":["https://orcid.org/0000-0002-3536-2920"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I2801748203","display_name":"Hammersmith Hospital","ror":"https://ror.org/05jg8yp15","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I153355300","https://openalex.org/I2801748203"]},{"id":"https://openalex.org/I4210128413","display_name":"GlaxoSmithKline (Italy)","ror":"https://ror.org/03fe56089","country_code":"IT","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210128413"]},{"id":"https://openalex.org/I4210145969","display_name":"Max Planck Institute of Psychiatry","ror":"https://ror.org/04dq56617","country_code":"DE","type":"facility","lineage":["https://openalex.org/I149899117","https://openalex.org/I4210145969"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["DE","GB","IT"],"is_corresponding":false,"raw_author_name":"Federica Tozzi","raw_affiliation_strings":["From the GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital, London, UK (BI, AWR, KR, TEN, PMM); Max Planck Institute of Psychiatry, Munich, Germany (PGS, DPA, FH); Genetics Division, Drug Discovery, Medicine Development Centre, GlaxoSmithKline, Research and Development, Verona, Italy (FT, PM); Experimental Medical Science, Psychiatry Centre of Excellence for Drug Discovery, Harlow-Verona, GlaxoSmithKline (EM); Department of Clinical Neuroscience, Imperial College, London, UK (BI, PMM)","Department of Clinical Neuroscience, Imperial College, London, UK (BI, PMM)","Experimental Medical Science, Psychiatry Centre of Excellence for Drug Discovery, Harlow-Verona, GlaxoSmithKline (EM)","From the GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital, London, UK (BI, AWR, KR, TEN, PMM)","Genetics Division, Drug Discovery, Medicine Development Centre, GlaxoSmithKline, Research and Development, Verona, Italy (FT, PM)","Max Planck Institute of Psychiatry, Munich, Germany (PGS, DPA, FH)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital, London, UK (BI, AWR, KR, TEN, PMM); Max Planck Institute of Psychiatry, Munich, Germany (PGS, DPA, FH); Genetics Division, Drug Discovery, Medicine Development Centre, GlaxoSmithKline, Research and Development, Verona, Italy (FT, PM); Experimental Medical Science, Psychiatry Centre of Excellence for Drug Discovery, Harlow-Verona, GlaxoSmithKline (EM); Department of Clinical Neuroscience, Imperial College, London, UK (BI, PMM)","institution_ids":["https://openalex.org/I188950975","https://openalex.org/I2801748203","https://openalex.org/I4210128413","https://openalex.org/I4210145969","https://openalex.org/I47508984"]},{"raw_affiliation_string":"Department of Clinical Neuroscience, Imperial College, London, UK (BI, PMM)","institution_ids":["https://openalex.org/I47508984"]},{"raw_affiliation_string":"Experimental Medical Science, Psychiatry Centre of Excellence for Drug Discovery, Harlow-Verona, GlaxoSmithKline (EM)","institution_ids":["https://openalex.org/I188950975"]},{"raw_affiliation_string":"From the GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital, London, UK (BI, AWR, KR, TEN, PMM)","institution_ids":["https://openalex.org/I2801748203"]},{"raw_affiliation_string":"Genetics Division, Drug Discovery, Medicine Development Centre, GlaxoSmithKline, Research and Development, Verona, Italy (FT, PM)","institution_ids":["https://openalex.org/I4210128413"]},{"raw_affiliation_string":"Max Planck Institute of Psychiatry, Munich, Germany (PGS, DPA, FH)","institution_ids":["https://openalex.org/I4210145969"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050995972","display_name":"Pierandrea Muglia","orcid":"https://orcid.org/0000-0002-3973-8606","observed_orcids":["https://orcid.org/0000-0002-3973-8606"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I2801748203","display_name":"Hammersmith Hospital","ror":"https://ror.org/05jg8yp15","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I153355300","https://openalex.org/I2801748203"]},{"id":"https://openalex.org/I4210128413","display_name":"GlaxoSmithKline (Italy)","ror":"https://ror.org/03fe56089","country_code":"IT","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210128413"]},{"id":"https://openalex.org/I4210145969","display_name":"Max Planck Institute of Psychiatry","ror":"https://ror.org/04dq56617","country_code":"DE","type":"facility","lineage":["https://openalex.org/I149899117","https://openalex.org/I4210145969"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["DE","GB","IT"],"is_corresponding":false,"raw_author_name":"Pierandrea Muglia","raw_affiliation_strings":["From the GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital, London, UK (BI, AWR, KR, TEN, PMM); Max Planck Institute of Psychiatry, Munich, Germany (PGS, DPA, FH); Genetics Division, Drug Discovery, Medicine Development Centre, GlaxoSmithKline, Research and Development, Verona, Italy (FT, PM); Experimental Medical Science, Psychiatry Centre of Excellence for Drug Discovery, Harlow-Verona, GlaxoSmithKline (EM); Department of Clinical Neuroscience, Imperial College, London, UK (BI, PMM)","Department of Clinical Neuroscience, Imperial College, London, UK (BI, PMM)","Experimental Medical Science, Psychiatry Centre of Excellence for Drug Discovery, Harlow-Verona, GlaxoSmithKline (EM)","From the GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital, London, UK (BI, AWR, KR, TEN, PMM)","Genetics Division, Drug Discovery, Medicine Development Centre, GlaxoSmithKline, Research and Development, Verona, Italy (FT, PM)","Max Planck Institute of Psychiatry, Munich, Germany (PGS, DPA, FH)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital, London, UK (BI, AWR, KR, TEN, PMM); Max Planck Institute of Psychiatry, Munich, Germany (PGS, DPA, FH); Genetics Division, Drug Discovery, Medicine Development Centre, GlaxoSmithKline, Research and Development, Verona, Italy (FT, PM); Experimental Medical Science, Psychiatry Centre of Excellence for Drug Discovery, Harlow-Verona, GlaxoSmithKline (EM); Department of Clinical Neuroscience, Imperial College, London, UK (BI, PMM)","institution_ids":["https://openalex.org/I188950975","https://openalex.org/I2801748203","https://openalex.org/I4210128413","https://openalex.org/I4210145969","https://openalex.org/I47508984"]},{"raw_affiliation_string":"Department of Clinical Neuroscience, Imperial College, London, UK (BI, PMM)","institution_ids":["https://openalex.org/I47508984"]},{"raw_affiliation_string":"Experimental Medical Science, Psychiatry Centre of Excellence for Drug Discovery, Harlow-Verona, GlaxoSmithKline (EM)","institution_ids":["https://openalex.org/I188950975"]},{"raw_affiliation_string":"From the GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital, London, UK (BI, AWR, KR, TEN, PMM)","institution_ids":["https://openalex.org/I2801748203"]},{"raw_affiliation_string":"Genetics Division, Drug Discovery, Medicine Development Centre, GlaxoSmithKline, Research and Development, Verona, Italy (FT, PM)","institution_ids":["https://openalex.org/I4210128413"]},{"raw_affiliation_string":"Max Planck Institute of Psychiatry, Munich, Germany (PGS, DPA, FH)","institution_ids":["https://openalex.org/I4210145969"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028670732","display_name":"Emilio Merlo\u2010Pich","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I2801748203","display_name":"Hammersmith Hospital","ror":"https://ror.org/05jg8yp15","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I153355300","https://openalex.org/I2801748203"]},{"id":"https://openalex.org/I4210128413","display_name":"GlaxoSmithKline (Italy)","ror":"https://ror.org/03fe56089","country_code":"IT","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210128413"]},{"id":"https://openalex.org/I4210145969","display_name":"Max Planck Institute of Psychiatry","ror":"https://ror.org/04dq56617","country_code":"DE","type":"facility","lineage":["https://openalex.org/I149899117","https://openalex.org/I4210145969"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["DE","GB","IT"],"is_corresponding":false,"raw_author_name":"Emilio Merlo-Pich","raw_affiliation_strings":["From the GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital, London, UK (BI, AWR, KR, TEN, PMM); Max Planck Institute of Psychiatry, Munich, Germany (PGS, DPA, FH); Genetics Division, Drug Discovery, Medicine Development Centre, GlaxoSmithKline, Research and Development, Verona, Italy (FT, PM); Experimental Medical Science, Psychiatry Centre of Excellence for Drug Discovery, Harlow-Verona, GlaxoSmithKline (EM); Department of Clinical Neuroscience, Imperial College, London, UK (BI, PMM)","Department of Clinical Neuroscience, Imperial College, London, UK (BI, PMM)","Experimental Medical Science, Psychiatry Centre of Excellence for Drug Discovery, Harlow-Verona, GlaxoSmithKline (EM)","From the GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital, London, UK (BI, AWR, KR, TEN, PMM)","Genetics Division, Drug Discovery, Medicine Development Centre, GlaxoSmithKline, Research and Development, Verona, Italy (FT, PM)","Max Planck Institute of Psychiatry, Munich, Germany (PGS, DPA, FH)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital, London, UK (BI, AWR, KR, TEN, PMM); Max Planck Institute of Psychiatry, Munich, Germany (PGS, DPA, FH); Genetics Division, Drug Discovery, Medicine Development Centre, GlaxoSmithKline, Research and Development, Verona, Italy (FT, PM); Experimental Medical Science, Psychiatry Centre of Excellence for Drug Discovery, Harlow-Verona, GlaxoSmithKline (EM); Department of Clinical Neuroscience, Imperial College, London, UK (BI, PMM)","institution_ids":["https://openalex.org/I188950975","https://openalex.org/I2801748203","https://openalex.org/I4210128413","https://openalex.org/I4210145969","https://openalex.org/I47508984"]},{"raw_affiliation_string":"Department of Clinical Neuroscience, Imperial College, London, UK (BI, PMM)","institution_ids":["https://openalex.org/I47508984"]},{"raw_affiliation_string":"Experimental Medical Science, Psychiatry Centre of Excellence for Drug Discovery, Harlow-Verona, GlaxoSmithKline (EM)","institution_ids":["https://openalex.org/I188950975"]},{"raw_affiliation_string":"From the GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital, London, UK (BI, AWR, KR, TEN, PMM)","institution_ids":["https://openalex.org/I2801748203"]},{"raw_affiliation_string":"Genetics Division, Drug Discovery, Medicine Development Centre, GlaxoSmithKline, Research and Development, Verona, Italy (FT, PM)","institution_ids":["https://openalex.org/I4210128413"]},{"raw_affiliation_string":"Max Planck Institute of Psychiatry, Munich, Germany (PGS, DPA, FH)","institution_ids":["https://openalex.org/I4210145969"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5070529061","display_name":"Paul McMahan Matthews","orcid":"https://orcid.org/0000-0002-1619-8328","observed_orcids":["https://orcid.org/0000-0002-1619-8328"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I2801748203","display_name":"Hammersmith Hospital","ror":"https://ror.org/05jg8yp15","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I153355300","https://openalex.org/I2801748203"]},{"id":"https://openalex.org/I4210128413","display_name":"GlaxoSmithKline (Italy)","ror":"https://ror.org/03fe56089","country_code":"IT","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210128413"]},{"id":"https://openalex.org/I4210145969","display_name":"Max Planck Institute of Psychiatry","ror":"https://ror.org/04dq56617","country_code":"DE","type":"facility","lineage":["https://openalex.org/I149899117","https://openalex.org/I4210145969"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["DE","GB","IT"],"is_corresponding":false,"raw_author_name":"Paul M. Matthews","raw_affiliation_strings":["Department of Clinical Neuroscience, Imperial College, London, UK (BI, PMM)","Experimental Medical Science, Psychiatry Centre of Excellence for Drug Discovery, Harlow-Verona, GlaxoSmithKline (EM)","From the GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital, London, UK (BI, AWR, KR, TEN, PMM)","Genetics Division, Drug Discovery, Medicine Development Centre, GlaxoSmithKline, Research and Development, Verona, Italy (FT, PM)","Max Planck Institute of Psychiatry, Munich, Germany (PGS, DPA, FH)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Neuroscience, Imperial College, London, UK (BI, PMM)","institution_ids":["https://openalex.org/I47508984"]},{"raw_affiliation_string":"Experimental Medical Science, Psychiatry Centre of Excellence for Drug Discovery, Harlow-Verona, GlaxoSmithKline (EM)","institution_ids":["https://openalex.org/I188950975"]},{"raw_affiliation_string":"From the GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital, London, UK (BI, AWR, KR, TEN, PMM)","institution_ids":["https://openalex.org/I2801748203"]},{"raw_affiliation_string":"Genetics Division, Drug Discovery, Medicine Development Centre, GlaxoSmithKline, Research and Development, Verona, Italy (FT, PM)","institution_ids":["https://openalex.org/I4210128413"]},{"raw_affiliation_string":"Max Planck Institute of Psychiatry, Munich, Germany (PGS, DPA, FH)","institution_ids":["https://openalex.org/I4210145969"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3750,"currency":"USD","value_usd":3750},"apc_paid":null,"fwci":1.9691,"has_fulltext":false,"cited_by_count":57,"citation_normalized_percentile":{"value":0.83524873,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"21","issue":"4","first_page":"375","last_page":"382"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.8687000274658203,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.8687000274658203,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10042","display_name":"Neural and Behavioral Psychology Studies","score":0.03370000049471855,"subfield":{"id":"https://openalex.org/subfields/2805","display_name":"Cognitive Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10241","display_name":"Functional Brain Connectivity Studies","score":0.024900000542402267,"subfield":{"id":"https://openalex.org/subfields/2805","display_name":"Cognitive Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.8399999737739563},{"id":"https://openalex.org/keywords/recurrent-depressive-disorder","display_name":"recurrent depression","score":0.9300000071525574},{"id":"https://openalex.org/keywords/anxiety-symptoms","display_name":"anxiety symptoms","score":0.8399999737739563},{"id":"https://openalex.org/keywords/comorbidity","display_name":"comorbidities","score":0.6909999847412109},{"id":"https://openalex.org/keywords/grey-matter-volume","display_name":"gray matter volume","score":0.9800000190734863},{"id":"https://openalex.org/keywords/brain-structure","display_name":"brain structure","score":0.5740000009536743},{"id":"https://openalex.org/keywords/right-temporal-cortex","display_name":"right temporal cortex","score":0.7680000066757202},{"id":"https://openalex.org/keywords/superior-parietal-lobule","display_name":"superior parietal lobule","score":0.9309999942779541},{"id":"https://openalex.org/keywords/voxel-based-morphometry","display_name":"voxel-based morphometry","score":0.6240000128746033}],"concepts":[{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.7992604374885559},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6420549154281616},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.6263911724090576},{"id":"https://openalex.org/C54170458","wikidata":"https://www.wikidata.org/wiki/Q663554","display_name":"Voxel","level":2,"score":0.5583977699279785},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.5519440174102783},{"id":"https://openalex.org/C2780621315","wikidata":"https://www.wikidata.org/wiki/Q5407200","display_name":"Middle temporal gyrus","level":3,"score":0.5025434494018555},{"id":"https://openalex.org/C143409427","wikidata":"https://www.wikidata.org/wiki/Q161238","display_name":"Magnetic resonance imaging","level":2,"score":0.47110918164253235},{"id":"https://openalex.org/C2779369059","wikidata":"https://www.wikidata.org/wiki/Q1758383","display_name":"Gyrus","level":2,"score":0.45061129331588745},{"id":"https://openalex.org/C200134340","wikidata":"https://www.wikidata.org/wiki/Q845664","display_name":"Voxel-based morphometry","level":4,"score":0.43998631834983826},{"id":"https://openalex.org/C2779144063","wikidata":"https://www.wikidata.org/wiki/Q338924","display_name":"Amygdala","level":2,"score":0.38673561811447144},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3764388859272003},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3405725955963135},{"id":"https://openalex.org/C2781192897","wikidata":"https://www.wikidata.org/wiki/Q822050","display_name":"White matter","level":3,"score":0.24716010689735413},{"id":"https://openalex.org/C126838900","wikidata":"https://www.wikidata.org/wiki/Q77604","display_name":"Radiology","level":1,"score":0.08285486698150635},{"id":"https://openalex.org/C169900460","wikidata":"https://www.wikidata.org/wiki/Q2200417","display_name":"Cognition","level":2,"score":0.06738519668579102},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001007","descriptor_name":"Anxiety","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D001007","descriptor_name":"Anxiety","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008279","descriptor_name":"Magnetic Resonance Imaging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1111/j.1552-6569.2010.00515.x","doi":"https://doi.org/10.1111/j.1552-6569.2010.00515.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1552-6569.2010.00515.x","pdf_url":null,"source":{"id":"https://openalex.org/S143223179","display_name":"Journal of Neuroimaging","issn_l":"1051-2284","issn":["1051-2284","1552-6569"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Neuroimaging","raw_type":"journal-article"},{"id":"pmid:20977527","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20977527","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of neuroimaging : official journal of the American Society of Neuroimaging","raw_type":"Journal Article"},{"id":"pmh:oai:edoc.mpg.de:573297","doi":null,"is_oa":false,"landing_page_url":"http://edoc.mpg.de/573297","pdf_url":null,"source":{"id":"https://openalex.org/S4406922265","display_name":"Max Planck Institute for Plasma Physics","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Neuroimaging, v.21, 375-382 (2011)","raw_type":"Article"},{"id":"pmh:oai:pure.mpg.de:item_1632908","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/11858/00-001M-0000-000E-8D9E-9","pdf_url":null,"source":{"id":"https://openalex.org/S4306400654","display_name":"MPG.PuRe (Max Planck Society)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I149899117","host_organization_name":"Max Planck Society","host_organization_lineage":["https://openalex.org/I149899117"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Neuroimaging","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":57,"referenced_works":["https://openalex.org/W166714271","https://openalex.org/W1582811168","https://openalex.org/W1719169697","https://openalex.org/W1945514973","https://openalex.org/W1967437213","https://openalex.org/W1979804471","https://openalex.org/W1988193785","https://openalex.org/W1990168531","https://openalex.org/W1990288178","https://openalex.org/W1993585744","https://openalex.org/W1999682854","https://openalex.org/W2000812314","https://openalex.org/W2018735264","https://openalex.org/W2022459144","https://openalex.org/W2041435129","https://openalex.org/W2043519044","https://openalex.org/W2044634376","https://openalex.org/W2049231844","https://openalex.org/W2058046532","https://openalex.org/W2060224258","https://openalex.org/W2061600075","https://openalex.org/W2061730652","https://openalex.org/W2069083186","https://openalex.org/W2075050732","https://openalex.org/W2076518150","https://openalex.org/W2081726701","https://openalex.org/W2083934855","https://openalex.org/W2090067353","https://openalex.org/W2092923627","https://openalex.org/W2093240504","https://openalex.org/W2095901107","https://openalex.org/W2096831423","https://openalex.org/W2101562854","https://openalex.org/W2111762674","https://openalex.org/W2113282160","https://openalex.org/W2117591375","https://openalex.org/W2118421222","https://openalex.org/W2119848633","https://openalex.org/W2119851912","https://openalex.org/W2121358117","https://openalex.org/W2129253531","https://openalex.org/W2132156834","https://openalex.org/W2137296158","https://openalex.org/W2138790588","https://openalex.org/W2140681531","https://openalex.org/W2144250533","https://openalex.org/W2146659162","https://openalex.org/W2156925279","https://openalex.org/W2161375784","https://openalex.org/W2167123432","https://openalex.org/W2169428430","https://openalex.org/W2171952522","https://openalex.org/W2319548838","https://openalex.org/W2397128295","https://openalex.org/W2400600349","https://openalex.org/W2611441866","https://openalex.org/W4239291492"],"related_works":["https://openalex.org/W2950883278","https://openalex.org/W1484532986","https://openalex.org/W4389411551","https://openalex.org/W2954855709","https://openalex.org/W3181133359","https://openalex.org/W4400609066","https://openalex.org/W2048420295","https://openalex.org/W7202131697","https://openalex.org/W2057519087","https://openalex.org/W4412913848"],"abstract_inverted_index":{"BACKGROUND":[0],"AND":[1],"PURPOSE:":[2],"Major":[3],"depressive":[4,21],"disorder":[5],"(MDD)":[6],"presents":[7],"with":[8,15,96,161],"extensive":[9],"clinical":[10],"heterogeneity.":[11],"In":[12],"particular,":[13],"overlap":[14],"anxiety":[16,51,184],"symptoms":[17,52,185],"is":[18],"common":[19],"during":[20],"episodes":[22],"and":[23,49,54,64,72,100,133,188],"as":[24],"a":[25,43],"comorbid":[26],"disorder.":[27],"The":[28,137,167],"aim":[29],"of":[30,45,61,68,83,183],"this":[31],"study":[32],"was":[33],"to":[34,180],"test":[35],"for":[36,79,192,197],"morphological":[37],"brain":[38],"differences":[39,156,170,178],"between":[40],"patients":[41,76,106,116,139,158],"having":[42],"history":[44],"recurrent":[46],"MDD":[47,138,174],"with,":[48],"without,":[50],"(MDD+A":[53],"MDD-A).":[55],"METHODS:":[56],"T1-weighted":[57],"magnetic":[58],"resonance":[59],"images":[60,92],"age-,":[62,98],"gender-":[63],"ethnically":[65],"matched":[66],"groups":[67,175,195],"MDD+A":[69,105],"(n=":[70,74],"49)":[71],"MDD-A":[73,115],"96)":[75],"were":[77,93],"available":[78],"voxel-based":[80],"morphometry":[81],"analysis":[82],"regional":[84],"gray":[85],"matter":[86],"(GM)":[87],"volume":[88,110,144,155],"differences.":[89],"Brain":[90],"structural":[91],"also":[94],"contrasted":[95],"183":[97],"gender-,":[99],"ethnicity-matched":[101],"healthy":[102,146],"controls.":[103],"RESULTS:":[104],"had":[107],"greater":[108],"GM":[109,143],"(P(FWE)":[111],"=":[112],".002)":[113],"than":[114,145],"in":[117,148,157,186],"the":[118,124,130,149,172,181],"right":[119],"temporal":[120,127,135],"cortex":[121],"extending":[122],"from":[123],"mid-posterior":[125],"superior":[126,150],"gyrus":[128],"into":[129],"posterior":[131],"middle":[132],"inferior":[134],"gyrus.":[136],"together":[140],"showed":[141],"lower":[142],"controls":[147],"parietal":[151],"lobe.":[152],"CONCLUSIONS:":[153],"Regional":[154],"are":[159],"consistent":[160],"altered":[162],"neuronal":[163],"or":[164],"glial":[165],"microstructure.":[166],"temporolateral":[168],"cortical":[169],"distinguishing":[171],"2":[173],"suggest":[176],"neurobiological":[177],"related":[179],"expression":[182],"depression":[187],"provide":[189],"further":[190],"rationale":[191],"considering":[193],"these":[194],"independently":[196],"therapeutic":[198],"outcomes":[199],"studies.":[200]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}